The invention relates to compounds of formula (I) and salts thereof: Formula (I) wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).
该发明涉及公式(I)化合物及其盐:公式(I)其中的取代基如说明书中所定义;用于治疗人体或动物体的公式(I)化合物,特别是针对c-Met
酪氨酸激酶介导的疾病或状况;使用公式(I)化合物来制造治疗此类疾病的药物;包含公式(I)化合物的药物组合物,可选地与联合用药伙伴一起使用,以及制备公式(I)化合物的方法。